TrialNo phaseRecruiting
Autophagy-Enhancers to Reduce Sleep Disturbances (SpSleep)
Autophagy-Enhancers to Reduce Sleep Disturbances: A Combined Approach
- Sponsor
- University Medicine Greifswald (Academic or other)
- Enrolment
- 76 planned
- Conditions
- Mild Cognitive Impairment Due to Alzheimer's Disease; Subjective Cognitive Decline (SCD)
- Interventions
- Spermidine Supplementation; Dietary Placebo
- Ages
- adults, older adults
- Registry
- NCT07383311
From the registry
This clinical trial investigates the effects of spermidine supplementation on sleep quality and sleep-dependent memory consolidation in older adults with Subjective Cognitive Decline (SCD) or Mild Cognitive Impairment (MCI), two populations at increased risk of future cognitive decline and dementia. Impaired sleep has been identified as a modifiable factor contributing to cognitive decline, and interventions targeting sleep architecture could offer therapeutic potential to prevent or slow down this decline. Spermidine is a naturally occurring polyamine found in foods such as wheat germ and soybeans. It induces autophagy, a cellular degradation and recycling process essential for neuronal maintenance and function. In animal studies, spermidine has been shown to improve memory performance, reduce neuroinflammation, and support mitochondrial health. Preliminary findings from human trials in individuals with SCD or MCI suggest potential cognitive benefits of spermidine, but results are not unequivocal, and the impact on sleep has not been systematically evaluated. In this randomized,…
Primary outcomes
- Effects of spermidine supplementation on sleep quality as measured by electroencephalography (EEG) mean power spectra
- Effects of spermidine supplementation on sleep quality as measured by sleep spindle count assessed from EEG
- Effects of spermidine supplementation on sleep quality as measured by sleep spindle power assessed from EEG
- Effects of spermidine supplementation on sleep-related alertness as measured by computer-based task